Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stella Grosser

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Statistical Methods in Medical Research|September 27, 2014
Statistical considerations in the design, analysis and interpretation of clinical studies that use patient-reported outcomesLisa A Kammerman, Stella Grosser
Journal of Biopharmaceutical Statistics|December 7, 2016
Ratio of means vs. difference of means as measures of superiority, noninferiority, and average bioequivalenceWanjie Sun, Stella Grosser, Yi Tsong
Pharmaceutical Statistics|March 11, 2026
Multiplicity Adjustment Methods for a Three-Way Crossover Bioequivalence StudyDavid Hinds, Stella Grosser, Wanjie Sun
Pharmaceutical Statistics|July 20, 2022
Comments on "Statistical methodology for highly variable compounds: A novel design approach for the ofatumumab phase 2 bioequivalence study"Wanjie Sun, Donald J Schuirmann, Stella Grosser
The AAPS Journal|September 9, 2024
Letter to the Editor on "Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies"Wanjie Sun, Mohamed Alosh, Donald J Schuirmann, et al.
Journal of Biopharmaceutical Statistics|September 10, 2019
Statistical considerations and impact of the FDA draft guidance for assessing adhesion with transdermal delivery systems and topical patches for ANDAsWanjie Sun, Stella Grosser, Carol Kim, et al.
Journal of Biopharmaceutical Statistics|May 15, 2026
Advances in statistical methodologies for assessing bioequivalence of topical dermatological productsElena Rantou, Namhee Choi, Sungwoo Choi, et al.
Therapeutic Innovation & Regulatory Science|June 20, 2020
FDA's Generic Drug Program: Decreasing Time to Approval and Number of Review CyclesHoward Chazin, Jason Woo, Jing Han, et al.
Clinical Pharmacology and Therapeutics|January 23, 2019
On Bayesian Analysis and Hypothesis Testing in the Determination of BioequivalenceDonald J Schuirmann, Stella Grosser, Somesh Chattopadhyay, et al.
Journal of Biopharmaceutical Statistics|June 18, 2024
Clustering plasma concentration-time curves: applications of unsupervised learning in pharmacogenomicsJackson P Lautier, Stella Grosser, Jessica Kim, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Statistical Methods in Medical Research|September 27, 2014
Statistical considerations in the design, analysis and interpretation of clinical studies that use patient-reported outcomesLisa A Kammerman, Stella Grosser
Journal of Biopharmaceutical Statistics|December 7, 2016
Ratio of means vs. difference of means as measures of superiority, noninferiority, and average bioequivalenceWanjie Sun, Stella Grosser, Yi Tsong
Pharmaceutical Statistics|March 11, 2026
Multiplicity Adjustment Methods for a Three-Way Crossover Bioequivalence StudyDavid Hinds, Stella Grosser, Wanjie Sun
Pharmaceutical Statistics|July 20, 2022
Comments on "Statistical methodology for highly variable compounds: A novel design approach for the ofatumumab phase 2 bioequivalence study"Wanjie Sun, Donald J Schuirmann, Stella Grosser
The AAPS Journal|September 9, 2024
Letter to the Editor on "Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies"Wanjie Sun, Mohamed Alosh, Donald J Schuirmann, et al.
Journal of Biopharmaceutical Statistics|September 10, 2019
Statistical considerations and impact of the FDA draft guidance for assessing adhesion with transdermal delivery systems and topical patches for ANDAsWanjie Sun, Stella Grosser, Carol Kim, et al.
Journal of Biopharmaceutical Statistics|May 15, 2026
Advances in statistical methodologies for assessing bioequivalence of topical dermatological productsElena Rantou, Namhee Choi, Sungwoo Choi, et al.
Therapeutic Innovation & Regulatory Science|June 20, 2020
FDA's Generic Drug Program: Decreasing Time to Approval and Number of Review CyclesHoward Chazin, Jason Woo, Jing Han, et al.
Clinical Pharmacology and Therapeutics|January 23, 2019
On Bayesian Analysis and Hypothesis Testing in the Determination of BioequivalenceDonald J Schuirmann, Stella Grosser, Somesh Chattopadhyay, et al.
Journal of Biopharmaceutical Statistics|June 18, 2024
Clustering plasma concentration-time curves: applications of unsupervised learning in pharmacogenomicsJackson P Lautier, Stella Grosser, Jessica Kim, et al.
Pageof 3